Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

ClinicalTrials.gov ID: NCT05246280

Public ClinicalTrials.gov record NCT05246280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Tc 99m Tilmanocept Imaging for the Early Prediction of Anti-TNFα Therapy Response in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα therapy.

Study identification

NCT ID
NCT05246280
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Navidea Biopharmaceuticals
Industry
Enrollment
169 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2, 2022 (Actual)
Primary completion
Jul 9, 2024 (Actual)
Completion
Jul 9, 2024 (Actual)
Last update posted
Jan 23, 2025

2022 – 2024

United States locations

U.S. sites
13
U.S. states
6
U.S. cities
13
Facility City State ZIP Site status
Attune Health Research Beverly Hills California 90211 —
University of California, San Francisco San Francisco California 94110 —
Highlands Advanced Rheumatology and Arthritis Center Avon Park Florida 33825 —
Believe Clinical Trials Coral Springs Florida 33065 —
Nouvelle Clinical Research Cutler Bay Florida 33189 —
Vida Clinical Research Kissimmee Florida 34741 —
Life Clinical Trials Margate Florida 33063 —
D&H National Research Centers, Inc Miami Florida 33155 —
Advanced Clinical Research of Orlando Ocoee Florida 34761 —
Physician Research Collaboration Lincoln Nebraska 68516 —
Essential Medical Research Tulsa Oklahoma 74137 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Arthritis and Osteoporosis Center of Coastal Bend Corpus Christi Texas 78415 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05246280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 23, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05246280 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →